SF0426OA6643/072026
13/07/2028
Active ingredient:
Ondansetron 8 mg.
Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).
Dosage form
Solution for Intramuscular or Intravenous Injection or Intravenous Infusion.
Active ingredient:40 mg Esomeprazole Therapeutic indications: Indicated for gastro-oesophageal Reflux...
Read More
Active ingredient:40 mg pantoprazole Therapeutic indications: Indicated for reflux oesophagitis,...
Read More
Active ingredient:25 mg diclofenac sodium Therapeutic indications:indicated for Relieving...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
